Market Cap

Fulgent Genetics, Inc. Market Capitalization:

$587.1 Million

USD as of July 1, 2024

business Fulgent Genetics, Inc. Company Profile

Fulgent Genetics, Inc. Main Stock Listing

NASDAQ: FLGT

Market Capitalization History of Fulgent Genetics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $204.45 B
Danaher $177.21 B
Siemens Healthineers AG $63.84 B
DexCom, Inc. $45.21 B
Lonza Group Ltd $39.85 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Fulgent Genetics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $835.1 M -15.33%
Jan. 1, 2023 $986.2 M -48.91%
Jan. 1, 2022 $1.93 B -42.19%
Jan. 1, 2021 $3.34 B 725.78%
Jan. 1, 2020 $404.4 M 236.18%
Jan. 1, 2019 $120.3 M -10.96%
Jan. 1, 2018 $135.1 M -65.80%
Jan. 1, 2017 $395.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Fulgent Genetics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Fulgent Genetics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: FLGT

Stock: BMV: FLGT

Stock: FSX: 7F0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.